PDCD1 and neoplasm: A triple combination of chidamide (50 mg/kg) + aspirin (50 mg/kg) + anti-PD-1 antibody significantly reduced the tumor volume, with primary tumor eradication in 3 out of 8 mice, and 37.5% survival at day 60 after tumor implantation (Fig. 4A,D–F).